Dow Up 1.21% Nasdaq Up 1.13%

Endocyte, Inc. (ECYT)

-NasdaqGS
3.23 Down 0.04(1.22%) 3:03PM EDT - Nasdaq Real Time Price
Prev Close:3.27
Open:3.25
Bid:3.23 x 1100
Ask:3.25 x 400
1y Target Est:8.25
Beta:1.53289
Earnings Date:Aug 2 - Aug 8 (Est.)
Day's Range:3.23 - 3.37
52wk Range:2.65 - 5.87
Volume:97,981
Avg Vol (3m):173,771
Market Cap:136.16M
P/E (ttm):N/A
EPS (ttm):-0.97
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ECYTDown 1.22%136.16M
SNSSUp 1.93%47.85M
NKTRUp 0.82%1.92B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,969.15
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.10
Quarterly EPS Est (Jun-16) :-0.26
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its technology to create novel small molecule drug conjugates (SMDCs) and compani... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback